T2 Biosystems Inc TTOO:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 6:23 AM EST
1.76quote price arrow down-0.19 (-9.74%)
Volume
49,682
Close
1.95quote price arrow down-0.08 (-3.94%)
Volume
10,207,793
52 week range
0.23 - 3.79

...

Loading . . .

KEY STATS

  • Open2.00
  • Day High2.06
  • Day Low1.82
  • Prev Close1.95
  • 52 Week High3.79
  • 52 Week High Date02/08/21
  • 52 Week Low0.23
  • 52 Week Low Date03/17/20
  • Market Cap288.52M
  • Shares Out147.96M
  • 10 Day Average Volume7.60M
  • Dividend-
  • Dividend Yield-
  • Beta0.41
  • 1 Year % Change225.71

RATIOS/PROFITABILITY

  • EPS (TTM)-0.68
  • P/E (TTM)-2.89
  • Fwd P/E (NTM)-7.50
  • EBITDA (MRQ)-42.201M
  • ROE (MRQ)-693.15%
  • Revenue (MRQ)13.41M
  • Gross Margin (MRQ)-25.37%
  • Net Margin (MRQ)-379.76%
  • Debt To Equity (MRQ)253.85%

EVENTS

  • Earnings Date05/06/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest T2 Biosystems Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
T2 Biosystems, Inc. is an in vitro diagnostics company engaged in developing a technology platform offering an alternative to diagnostic methodologies. The Company's T2 Magnetic Resonance platform (T2MR) enables detection of pathogens, biomarkers and other abnormalities in a range of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as one colony forming unit per milliliter...
John McDonough
Non-Executive Chairman
John Sperzel III
President
Alec Barclay
Chief Operating Officer
John Sprague
Chief Financial Officer
Michael Gibbs Esq
Vice President
Address
101 Hartwell Ave
Lexington, MA
02421-3125
United States